Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

McLornan, D.P.; Szydlo, R.; Robin, M.; Biezen, A. van; Koster, L.; Blok, H.J.P.; ... ; Kroger, N. (2018)

Article / Letter to editor

• mylelofibrosis
• allogeneic stem cell transplant
• fibrosis
• JAK inhibitors
• relapse

• All authors: McLornan, D.P.; Szydlo, R.; Robin, M.; Biezen, A. van; Koster, L.; Blok, H.J.P.; Lint, M.T. van; Finke, J.; Vitek, A.; Carlson, K.; Griskevicius, L.; Holler, E.; Itala-Remes, M.; Schaap, M.; Socie, G.; Bay, J.O.; Beguin, Y.; Bruno, B.; Cornelissen, J.J.; Gedde-Dahl, T.; Ljungman, P.; Rubio, M.T.; Yakoub-Agha, I.; Klyuchnikov, E.; Olavarria, E.; Chalandon, Y.; Kroger, N.
• Date: 2018-08-31
• Journal: British Journal of Haematology
• Volume: 182
• Issue: 3
• Pages: 418 - 422
• DOI: doi:10.1111/bjh.15407